Search
Last update: : 12.02.2025
Our Research The D3lab emerged from the DKFZ-Bayer Immunotherapeutics laboratory that over the past 10 years served as the hub for immuno-oncology (I.O.) drug development in the context of the…
Last update: : 12.02.2025
Our Research Our research group investigates various possibilities for optimizing T cell-mediated tumor defense and prepares their application together with clinical cooperation partners. In our…
Last update: : 12.02.2025
The Topics missions are twofold: To understand immune reactivity to and develop effective immunotherapies for cancer through single-cell analyses and targeted manipulation of immune cells from…
Last update: : 12.02.2025
Integrating recent advances in the fields of genetic and molecular biology, digital oncology and imaging will further boost progress in cancer prevention. Our research topic The…
Last update: : 12.02.2025
GERMAN CANCER AID AND DKFZ – OCTOBER 2023 Memorandum on cancer prevention research in Germany With support from German Cancer Aid (Deutsche Krebshilfe) was founded on September 25, 1974 by Dr…
DocumentLast update: : 12.02.2025
We develop and operate national IT infrastructures for the secure exchange of patient data, for example between the university hospitals in the German Consortium for Translational Cancer…
Last update: : 11.02.2025
DKFZ Postdoc Internship Program (PIP) / FAQs (Frequently Asked Questions) Tuesday, 11 February 2025 DKFZ Postdoc Internship Program (PIP) 1 January 2025 - 30 March 2025 FAQs (Frequently Asked…
DocumentLast update: : 11.02.2025
Team GMP & T cell therapy head of research group Prof. Dr. Stefan Eichmüller research unit Dr. Wolfram Osen, group leader preclinical research Felix Andres, PhD Student Elke…